Anticipated Earnings Release: Co-Diagnostics, Inc. (NASDAQ:CODX) is set to announce its Q4 and full-year 2025 financial results on March 31, 2026, with an expected EPS of -$3.60.Financial Metrics Overview: CODX showcases a mixed financial outlook with a price-to-sales ratio of 4.44 and an enterprise value to operating cash flow ratio of 0.25, indicating positive market perception and efficient cash flow conversion, respectively.Challenges Ahead: Despite strong liquidity and a conservative capital structure, ...